Quest Diagnostics, Inc.

DGX

$145.36

+13.0% (1 year change)

Market Cap

$17.3 Billion

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

52 Week Range

$103.09 - $142.80

The lowest and highst price in the last 52 weeks.

Price-Earnings Ratio

7.71x

The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

Dividends per Share

$2.35 (1.67%)

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Revenue & Earnings

Balance Sheet

Share Statistics

Market Cap $17.3 Billion
Enterprise Value $20 Billion
Dividend Yield $2.35 (1.67%)
1 Year Return +14.7%
52-Week High $142.80
52-Week Low $103.09
Beta 0.18
Outstanding Shares 122 Million
Avg 30 Day Volume 1.02 Million

Valuation

P/E Ratio 7.71
PEG 2.07
Earnings per Share $16.73
Price to Sales Ratio 1.73
Price to Book Ratio 2.64
Revenue to Enterprise Value 1.94
EBIT to Enterprise Value 7.91
Total Debt to Enterprise Value 0.2
Debt to Equity 0.59

Profitability

Revenue $10.3 Billion
Gross Profit $4.18 Billion
EBIT $2.53 Billion
Net Income $1.79 Billion
Profit Margin 17.36%
Quarterly Earnings Growth (YoY) +372.7%
Return on Equity 26.6%
Return on Assets 12.88%
Return on Invested Capital 20.73%

Quest Diagnostics, Inc.

Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our 47,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives.

News

Quest Diagnostics Inc (DGX) Chairman, CEO and President Stephen H Rusckowski Sold $20. ...

Quest Diagnostics Inc (DGX) Chairman, CEO and President Stephen H Rusckowski Sold $20. ...

Related Stocks: DGX ,

GuruFocus GuruFocus, 5 days ago
Quest Diagnostics Inc (DGX) Chairman, CEO and President Stephen H Rusckowski Sold $5. ...

Quest Diagnostics Inc (DGX) Chairman, CEO and President Stephen H Rusckowski Sold $5. ...

Related Stocks: DGX ,

GuruFocus GuruFocus, 7 days ago
Zika Virus Testing Market Forecast & Opportunities, 2028 | Luminex Corporation, NecLife, GenBody Inc, RapiGEN Inc, Quest Diagnostics

Zika Virus Testing Market Forecast & Opportunities, 2028 | Luminex Corporation, NecLife, GenBody Inc, RapiGEN Inc, Quest Diagnostics

Zika Virus, a mosquito borne disease mainly affects the pregnant women and their fetus. Though there are no particular vaccine developed against the virus, the treatment prevails for cure of the af...

OpenPR OpenPR, 9 days ago